PTK2 and neuroblastoma: MYCN, which is the most important negative prognostic factor in neuroblastoma, has been demonstrated to bind the FAK promoter, subsequently increasing the production of FAK in MYCN amplified cells; thus, enhancing its role in this particular malignancy3.